• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿卵巢肿瘤中分子标志物的评估:罗马尼亚单中心经验。

Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience.

机构信息

2nd Department of Surgery-Pediatric Surgery and Orthopedics, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.

Department of Mother and Child, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iași, Romania.

出版信息

Int J Mol Sci. 2024 Jun 19;25(12):6752. doi: 10.3390/ijms25126752.

DOI:10.3390/ijms25126752
PMID:38928458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11204196/
Abstract

Pediatric ovarian tumors exhibit unique diagnostic and therapeutic challenges. This study evaluates the expression of SALL4 and OCT3/4 biomarkers in pediatric ovarian tumors and their associations with tumor subtype, stage, and clinical outcome. A retrospective analysis was conducted on 64 patients under 18 years old, examining demographic data, tumor characteristics, immunohistochemical staining, and clinical outcomes. Our results show that SALL4 was significantly expressed in adenocarcinoma, dysgerminoma (DSG), mixed germ cell tumors (GCTs), and immature teratoma, while OCT3/4 was highly expressed in DSG and mixed GCTs. Both markers are associated with a higher tumor grade and stage, indicating a more aggressive disease. The SALL4 positivity expression was correlated with high alpha fetoprotein (AFP) and lactate dehydrogenase (LDH) levels, while OCT3/4 positivity significantly predicted the risk of subsequent metastasis. The mean progression-free survival (PFS) was notably shorter in patients with positive markers. These findings underscore the diagnostic and prognostic value of SALL4 and OCT3/4 in pediatric ovarian tumors, aligning with previous research and supporting their use in clinical practice for better disease management and patient outcomes.

摘要

小儿卵巢肿瘤具有独特的诊断和治疗挑战。本研究评估了 SALL4 和 OCT3/4 生物标志物在小儿卵巢肿瘤中的表达及其与肿瘤亚型、分期和临床结局的关系。对 64 名 18 岁以下的患者进行了回顾性分析,检查了人口统计学数据、肿瘤特征、免疫组织化学染色和临床结果。我们的结果表明,SALL4 在腺癌、生殖细胞瘤(DSG)、混合生殖细胞瘤(GCT)和未成熟畸胎瘤中显著表达,而 OCT3/4 在 DSG 和混合 GCT 中高表达。这两种标志物都与更高的肿瘤分级和分期相关,表明疾病更具侵袭性。SALL4 阳性表达与高甲胎蛋白(AFP)和乳酸脱氢酶(LDH)水平相关,而 OCT3/4 阳性显著预测了随后转移的风险。阳性标志物患者的无进展生存期(PFS)明显缩短。这些发现强调了 SALL4 和 OCT3/4 在小儿卵巢肿瘤中的诊断和预后价值,与之前的研究一致,并支持在临床实践中使用它们,以更好地管理疾病和改善患者结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/e977b33de7f2/ijms-25-06752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/8a0d2a0938f0/ijms-25-06752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/0cf9475e51d8/ijms-25-06752-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/e977b33de7f2/ijms-25-06752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/8a0d2a0938f0/ijms-25-06752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/0cf9475e51d8/ijms-25-06752-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/90c5/11204196/e977b33de7f2/ijms-25-06752-g003.jpg

相似文献

1
Assessment of Molecular Markers in Pediatric Ovarian Tumors: Romanian Single-Center Experience.小儿卵巢肿瘤中分子标志物的评估:罗马尼亚单中心经验。
Int J Mol Sci. 2024 Jun 19;25(12):6752. doi: 10.3390/ijms25126752.
2
Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.胚胎干细胞转录因子和D2-40(血小板内皮细胞黏附分子)作为卵巢生殖细胞肿瘤诊断的免疫组织化学标志物
Int J Gynecol Pathol. 2009 Jul;28(4):347-55. doi: 10.1097/PGP.0b013e318195da86.
3
Expression pattern of clinically relevant markers in paediatric germ cell- and sex-cord stromal tumours is similar to adult testicular tumours.儿科生殖细胞和性索间质肿瘤中临床相关标志物的表达模式与成人睾丸肿瘤相似。
Virchows Arch. 2014 Nov;465(5):567-77. doi: 10.1007/s00428-014-1635-1. Epub 2014 Jul 30.
4
Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation.卵巢未成熟畸胎瘤中 Oct4 的表达:与组织学分级和分化程度的相关性。
Am J Surg Pathol. 2010 Dec;34(12):1842-8. doi: 10.1097/PAS.0b013e3181fcd707.
5
SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.SALL4是卵巢原始生殖细胞肿瘤一种新的敏感且特异的标志物,在鉴别卵黄囊瘤和透明细胞癌方面尤为有用。
Am J Surg Pathol. 2009 Jun;33(6):894-904. doi: 10.1097/PAS.0b013e318198177d.
6
Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.卵巢胚胎性癌的形态学、免疫组织化学和荧光原位杂交研究,并与卵黄囊瘤的实体型变体和未成熟畸胎瘤进行比较。
Hum Pathol. 2010 May;41(5):716-23. doi: 10.1016/j.humpath.2009.10.016. Epub 2010 Jan 21.
7
Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma.癌干细胞标志物 SALL4/ALDH1A1 的共表达与浆液性卵巢癌患者的肿瘤侵袭性和不良预后相关。
J Ovarian Res. 2022 Jan 28;15(1):17. doi: 10.1186/s13048-021-00921-x.
8
SALL4 is a novel diagnostic marker for testicular germ cell tumors.SALL4 是睾丸生殖细胞肿瘤的一种新型诊断标志物。
Am J Surg Pathol. 2009 Jul;33(7):1065-77. doi: 10.1097/PAS.0b013e3181a13eef.
9
Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.新型干细胞标志物 SALL4、OCT4、NANOG、SOX2、UTF1 和 TCL1 在原发性纵隔生殖细胞肿瘤中的诊断效用。
Am J Surg Pathol. 2010 May;34(5):697-706. doi: 10.1097/PAS.0b013e3181db84aa.
10
Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary.CD117、CD133、SALL4、OCT4、TCL1和磷脂酰肌醇蛋白聚糖-3在卵巢恶性生殖细胞肿瘤中的诊断效用
J Obstet Gynaecol Res. 2012 May;38(5):841-8. doi: 10.1111/j.1447-0756.2011.01798.x. Epub 2012 Mar 26.

引用本文的文献

1
Diagnostic Value of SALL4 and OCT3/4 in Pediatric Testicular Tumors.SALL4和OCT3/4在小儿睾丸肿瘤中的诊断价值
Diagnostics (Basel). 2024 Jul 8;14(13):1454. doi: 10.3390/diagnostics14131454.

本文引用的文献

1
Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer-Drug Carriers Matter.用于癌症治疗中靶向STAT3的基于寡核苷酸的疗法——药物载体很重要。
Cancers (Basel). 2023 Nov 29;15(23):5647. doi: 10.3390/cancers15235647.
2
The new advance of SALL4 in cancer: Function, regulation, and implication.SALL4 在癌症中的新进展:功能、调控及意义。
J Clin Lab Anal. 2023 May;37(9-10):e24927. doi: 10.1002/jcla.24927. Epub 2023 Jun 20.
3
Oct-4 induces cisplatin resistance and tumor stem cell-like properties in endometrial carcinoma cells.
八聚体转录因子4(Oct-4)诱导子宫内膜癌细胞产生顺铂耐药性及肿瘤干细胞样特性。
Taiwan J Obstet Gynecol. 2023 Jan;62(1):16-21. doi: 10.1016/j.tjog.2022.08.014.
4
Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.卵巢浆液性黏液性交界性肿瘤和浆液性黏液性癌的临床病理特征及ARID1A表达缺失
Int J Surg Pathol. 2023 Jun;31(4):398-408. doi: 10.1177/10668969221134695. Epub 2022 Nov 30.
5
Multidrug Resistance of Cancer Cells and the Vital Role of P-Glycoprotein.癌细胞的多药耐药性与P-糖蛋白的重要作用。
Life (Basel). 2022 Jun 15;12(6):897. doi: 10.3390/life12060897.
6
SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance.SALL4 在癌症中的致癌功能:机制和治疗相关性。
Int J Mol Sci. 2022 Feb 12;23(4):2053. doi: 10.3390/ijms23042053.
7
An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells.一种用于癌症的替代性细胞疗法:诱导多能干细胞(iPSC)衍生的自然杀伤细胞。
Biomedicines. 2021 Sep 26;9(10):1323. doi: 10.3390/biomedicines9101323.
8
Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents.EXPeRT/PARTNER 专家组关于儿童和青少年性索间质肿瘤诊断和治疗的共识建议。
Pediatr Blood Cancer. 2021 Jun;68 Suppl 4:e29017. doi: 10.1002/pbc.29017. Epub 2021 Mar 24.
9
STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells.STAT3 抑制剂萘泊昔康抑制人卵巢癌细胞的生长并与蛋白酶体抑制剂协同作用。
Recent Pat Anticancer Drug Discov. 2021;16(3):350-362. doi: 10.2174/1574892816666210224155403.
10
Napabucasin overcomes cisplatin resistance in ovarian germ cell tumor-derived cell line by inhibiting cancer stemness.那帕布卡辛通过抑制肿瘤干性克服卵巢生殖细胞肿瘤来源细胞系中的顺铂耐药性。
Cancer Cell Int. 2020 Aug 3;20:364. doi: 10.1186/s12935-020-01458-7. eCollection 2020.